| Rubella |
|
| Virus classification |
| Group: |
Group IV ((+)ssRNA) |
| Family: |
Togaviridae |
| Genus: |
Rubivirus |
| Species: |
Rubella virus |
- This page is for the virus. For the disease, see Rubella.
Rubella virus is the pathogenic agent of the disease Rubella, and is the cause of congenital rubella syndrome when infection occurs during the first weeks of pregnancy. Humans are the only known host of this virus.
Rubella virus is the only member of the genus of Rubivirus and belongs to the family of Togaviridae, whose members commonly have a genome of single-stranded RNA of positive polarity which is enclosed by an icosahedral capsid.
The molecular basis for the causation of congenital rubella syndrome are not yet completely clear, but in vitro studies with cell lines showed that Rubella virus has an apoptotic effect on certain cell types. There is evidence for a p53-dependent mechanism.[1]
Contents
- 1 Structure
- 2 Genome
- 3 Replication
- 4 Capsid protein
- 5 Epidemiology
- 6 Literature
- 7 References
- 8 External links
Structure[edit source | edit]
The spherical virus particles (virions) of Togaviridae have a diameter of 50 to 70 nm and are covered by a lipid membrane (viral envelope), derived from the host cell membrane. There are prominent "spikes" (projections) of 6 nm composed of the viral envelope proteins E1 and E2 embedded in the membrane.[2]
Inside the lipid envelope is a capsid of 40 nm in diameter.
The E1 glycoprotein is considered immunodominant in the humoral response induced against the structural proteins and contains both neutralizing and hemagglutinating determinants.
Genome[edit source | edit]
The genome has 9,762 nucleotides and encodes 2 nonstructural polypeptides (p150 and p90) within its 5′-terminal two-thirds and 3 structural polypeptides (C, E2, and E1) within its 3′-terminal one-third.[3] Both envelope proteins E1 and E2 are glycosylated.
There are three sites that are highly conserved in togviruses: a stem-and-loop structure at the 5' end of the genome, a 51-nucleotide conserved sequence near the 5' end of the genome and a 20-nucleotide conserved sequence at the subgenomic RNA start site. Homologous sequenes are present in the rubella genome.[4]
The genome encodes several non-coding RNA structures; among them is the rubella virus 3' cis-acting element, which contains multiple stem-loops, one of which has been found to be essential for viral replication.[5]
The only significant region of homology between rubella and the alphaviruses is located at the NH2 terminus of non structural protein 3. This sequence has helicase and replicase activity. In the rubella genome these occur in the opposite orientation to that found in the alphaviruses indicating that a genome rearrangement has occurred.
The genome has the highest G+C content of any currently known single stranded RNA virus (~70%).[6] Despite this high GC content its codon use is similar to that of its human host.
Replication[edit source | edit]
The virus attach to the cell surface via specific receptors and are taken up by an endosome being formed. At the neutral pH outside of the cell the E2 envelope protein covers the E1 protein. The dropping pH inside the endosome frees the outer domain of E1 and causes the fusion of the viral envelope with the endosomal membrane. Thus, the capsid reaches the cytosol, decays and releases the genome
The (+)ssRNA (positive, single-stranded RNA) at first only acts as a template for the translation of the non-structural proteins, which are synthesized as a large polyprotein and are then cut into single proteins. The sequences for the structural proteins are first replicated by the viral RNA polymerase (Replicase) via a complementary (-)ssRNA as a template and translated as a separate short mRNA. This short subgenomic RNA is additionally packed in a virion.[7]
Translation of the structural proteins produces a large polypeptide (110 Dalton). This is then endoproteolytically cut into E1, E2 and the capsid protein. E1 and E2 are type I transmembrane proteins which are transported into the endoplasmatic reticulum (ER) with the help of an N-terminal signal sequence. From the ER the heterodimeric E1·E2-complex reaches the Golgi apparatus, where the budding of new virions occurs (unlike alpha viruses, where budding occurs at the plasma membrane. The capsid proteins on the other hand stay in the cytoplasm and interact with the genomic RNA, together forming the capsid.[8]
Capsid protein[edit source | edit]
The capsid protein (CP) has different functions.[9] Its main tasks are the formation of homooligomeres to form the capsid, and the binding of the genomic RNA. Further is it responsible for the aggregation of RNA in the capsid, it interacts with the membrane proteins E1 and E2 and binds the human host-protein p32 which is important for replication of the virus in the host.[10]
As opposed to alpha viruses the capsid does not undergo autoprotolysis, rather is it cut off from the rest of the polyprotein by the signal-peptidase. Production of the capsid happens at the surface of intracellular membranes simultaneously with the budding of the virus.[11]
Epidemiology[edit source | edit]
On the basis of differences in the sequence of the E1 protein two genotypes have been described that differing by 8 - 10%. These have been subdivided into 13 recognised genotypes - 1a, 1B, 1C, 1D, 1E, 1F, 1G, 1h, 1i, 1j, 2A, 2B and 2C.
For typing, the WHO recommends a minimum window that includes nucleotides 8731 to 9469.[12]
Genotypes 1a, 1E, 1F, 2A and 2B have been isolated in China.
Genotype 1j has only been isolated from Japan and the Philippines.
Genotype 1E is found in Africa, the Americas, Asia and Europe.
Genotype 1G has been isolated in Belarus, Cote d'Ivoire and Uganda.
Genotype 1C is endemic only in Central and South America.
Genotype 2B has been isolated in South Africa.
Genotype 2C has been isolated in Russia.
Literature[edit source | edit]
- David M. Knipe, Peter M. Howley et al. (eds.): Fields´ Virology 4. Auflage, Philadelphia 2001
- C.M. Fauquet, M.A. Mayo et al.: Eighth Report of the International Committee on Taxonomy of Viruses, London San Diego 2005
References[edit source | edit]
- ^ Megyeri K, Berencsi K, Halazonetis TD, et al (June 1999). "Involvement of a p53-dependent pathway in rubella virus-induced apoptosis". Virology 259 (1): 74–84. doi:10.1006/viro.1999.9757. PMID 10364491.
- ^ Bardeletti G, Kessler N, Aymard-Henry M (1975). "Morphology, biochemical analysis and neuraminidase activity of rubella virus". Arch. Virol. 49 (2–3): 175–86. doi:10.1007/BF01317536. PMID 1212096.
- ^ Dominguez G, Wang CY, Frey TK (July 1990). "Sequence of the genome RNA of rubella virus: evidence for genetic rearrangement during togavirus evolution". Virology 177 (1): 225–38. doi:10.1016/0042-6822(90)90476-8. PMID 2353453.
- ^ Dominguez G, Wang CY, Frey TK (1990) Sequence of the genome RNA of rubella virus: evidence for genetic rearrangement during togavirus evolution. Virology 177(1):225-238
- ^ Chen, MH; Frey TK (1999). "Mutagenic analysis of the 3' cis-acting elements of the rubella virus genome". J Virol 73 (4): 3386–3403. PMC 104103. PMID 10074193.
- ^ Zhou Y, Chen X, Ushijima H, Frey TK (2012) Analysis of base and codon usage by rubella virus. Arch Virol
- ^ "Togaviridae- Classification and Taxonomy".
- ^ Garbutt M, Law LM, Chan H, Hobman TC (May 1999). "Role of rubella virus glycoprotein domains in assembly of virus-like particles". J. Virol. 73 (5): 3524–33. PMC 104124. PMID 10196241.
- ^ Chen MH, Icenogle JP (April 2004). "Rubella virus capsid protein modulates viral genome replication and virus infectivity". Journal of Virology 78 (8): 4314–22. PMC 374250. PMID 15047844.
- ^ Beatch MD, Everitt JC, Law LJ, Hobman TC (August 2005). "Interactions between rubella virus capsid and host protein p32 are important for virus replication". J. Virol. 79 (16): 10807–20. doi:10.1128/JVI.79.16.10807-10820.2005. PMC 1182682. PMID 16051872.
- ^ Beatch MD, Hobman TC (June 2000). "Rubella virus capsid associates with host cell protein p32 and localizes to mitochondria". J. Virol. 74 (12): 5569–76. doi:10.1128/JVI.74.12.5569-5576.2000. PMC 112044. PMID 10823864.
- ^ "Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses". Wkly Epidemiol Rec 80 (14): 126–132. 2005. PMID 15850226.
External links[edit source | edit]
|
Baltimore (virus classification)
|
|
| DNA |
|
I: dsDNA viruses
|
|
|
Caudovirales
|
- Myoviridae
- Podoviridae
- Siphoviridae
|
|
|
Herpesvirales
|
- Alloherpesviridae
- Herpesviridae
- Malacoherpesviridae
|
|
|
Ligamenvirales
|
- Lipothrixviridae
- Rudiviridae
|
|
|
Unassigned
|
- NLCDV: Asfarviridae
- Iridoviridae
- Marseilleviridae
- Megaviridae
- Mimiviridae
- Phycodnaviridae
- Poxviridae
- nonenveloped: Adenoviridae
- Papillomaviridae
- Papovaviridae (obsolete)
- Polyomaviridae
- Ampullaviridae
- Ascoviridae
- Baculoviridae
- Bicaudaviridae
- Clavaviridae
- Corticoviridae
- Fuselloviridae
- Globuloviridae
- Guttaviridae
- Hytrosaviridae
- Nimaviridae
- Plasmaviridae
- Tectiviridae
|
|
|
|
|
II: ssDNA viruses
|
|
- Anelloviridae
- Bacillariodnaviridae
- Circoviridae
- Geminiviridae
- Inoviridae
- Microviridae
- Nanoviridae
- Parvoviridae
|
|
|
|
| RNA |
|
III: dsRNA viruses
|
|
- Birnaviridae
- Chrysoviridae
- Cystoviridae
- Hypoviridae
- Partitiviridae
- Reoviridae
- Totiviridae
|
|
|
|
IV: (+)ssRNA viruses (primarily icosahedral)
|
|
|
Nidovirales
|
- Arteriviridae
- Coronaviridae
- Roniviridae
|
|
|
Picornavirales
|
- Dicistroviridae
- Iflaviridae
- Marnaviridae
- Picornaviridae
- Secoviridae
|
|
|
Tymovirales
|
- Alphaflexiviridae
- Betaflexiviridae
- Gammaflexiviridae
- Tymoviridae
|
|
|
Unassigned
|
- Astroviridae
- Barnaviridae
- Bromoviridae
- Caliciviridae
- Closteroviridae
- Comoviridae
- Flaviviridae
- Flexiviridae
- Leviviridae
- Luteoviridae
- Narnaviridae
- Nodaviridae
- Potyviridae
- Sequiviridae
- Tetraviridae
- Togaviridae
- Tombusviridae
|
|
|
|
|
V: (-)ssRNA viruses (primarily helical)
|
|
|
Mononegavirales
|
- Bornaviridae
- Filoviridae
- Paramyxoviridae
- Rhabdoviridae
|
|
|
Unassigned
|
- Arenaviridae
- Bunyaviridae
- Orthomyxoviridae
|
|
|
|
|
| RT |
|
VI: ssRNA-RT viruses
|
|
- Metaviridae
- Pseudoviridae
- Retroviridae
|
|
|
|
VII: dsDNA-RT viruses
|
|
- Caulimoviridae
- Hepadnaviridae
|
|
|
|
|
|
|
cutn/syst (hppv/hiva, infl/zost/zoon)/epon
|
drug (dnaa, rnaa, rtva, vacc)
|
|
|
|
|
Infectious skin disease: Viral cutaneous conditions, including viral exanthema (B00–B09, 050–059)
|
|
|
DNA virus
|
|
Herpesviridae
|
|
Alpha
|
HSV (Herpes simplex, Herpetic whitlow, Herpes gladiatorum, Herpetic keratoconjunctivitis, Herpetic sycosis, Neonatal herpes simplex, Herpes genitalis, Herpes labialis, Eczema herpeticum, Herpetiform esophagitis) · Herpes B virus (B virus infection)
VZV (Chickenpox, Herpes zoster, Herpes zoster oticus, Ophthalmic zoster, Disseminated herpes zoster, Zoster-associated pain, Inflammatory skin lesions following zoster infection, Modified varicella-like syndrome)
|
|
|
Beta
|
Human herpesvirus 6/Roseolovirus (Exanthema subitum, Roseola vaccinia)
Cytomegalic inclusion disease
|
|
|
Gamma
|
KSHV (Kaposi's sarcoma)
|
|
|
|
Poxviridae
|
|
Ortho
|
Variola (Smallpox, Alastrim) · MoxV (Monkeypox) · CV (Cowpox) · VV (Vaccinia, Generalized vaccinia, Eczema vaccinatum, Progressive vaccinia)
Buffalopox
|
|
|
Para
|
Farmyard pox: Milker's nodule · Bovine papular stomatitis · Pseudocowpox · Orf
Sealpox
|
|
|
Other
|
Yatapoxvirus: Tanapox · Yaba monkey tumor virus
MCV (Molluscum contagiosum)
|
|
|
|
Papillomaviridae
|
HPV (Wart/Plantar wart, Heck's disease, Genital wart (giant), Laryngeal papillomatosis, Butcher's wart, Bowenoid papulosis, Epidermodysplasia verruciformis, Verruca plana, Pigmented wart, Verrucae palmares et plantares )
BPV (Equine sarcoid)
|
|
|
Parvoviridae
|
Parvovirus B19 (Erythema infectiosum, Reticulocytopenia, Papular purpuric gloves and socks syndrome)
|
|
|
Polyomaviridae
|
Merkel Cell Polyomavirus (Merkel Cell carcinoma)
|
|
|
|
RNA virus
|
|
Paramyxoviridae
|
MeV (Measles)
|
|
|
Togaviridae
|
Rubella virus (Rubella, Congenital rubella syndrome) · Alphavirus infection · Chikungunya fever
|
|
|
Picornaviridae
|
CAV (Hand, foot and mouth disease, Herpangina) · FMDV (Foot-and-mouth disease) · Boston exanthem disease
|
|
|
|
| Ungrouped |
unknown/multiple: Asymmetric periflexural exanthem of childhood · Post-vaccination follicular eruption · Lipschütz ulcer · Eruptive pseudoangiomatosis · Viral-associated trichodysplasia · Gianotti–Crosti syndrome
|
|
|
|
|
cutn/syst (hppv/hiva, infl/zost/zoon)/epon
|
drug (dnaa, rnaa, rtva, vacc)
|
|
|
|
|
noco (i/b/d/q/u/r/p/m/k/v/f)/cong/tumr (n/e/d), sysi/epon
|
proc, drug (D2/3/4/5/8/11)
|
|
|
|
